According to PwC, the global women’s health sector could reach $600 billion by 2030, but given underdiagnosis and new digital and consumer-driven models, the opportunity could be even greater.
The current global women’s health market is estimated to be between $430 billion and $440 billion, with annual growth rates of 6% to 8% by 2030, according to a new analysis (PDF).
Additionally, the core women’s health market, from gynecological conditions to oncology, is currently estimated at $195 billion to $205 billion and is projected to reach $270 billion to $280 billion by 2030.
Citing a January 2026 World Economic Forum report, researchers said that despite representing around half of the population, women’s health currently accounts for around 5% of total healthcare R&D and investment funding.
“This gap is not simply a capital difference, but may reflect structural inefficiencies in how health care markets are defined and financed,” the report said.
Researchers say a “broader lens” needs to be applied when defining women’s health, including conditions that are unique to women, that affect women differently, and that disproportionately affect women.
Expanding this definition not only reflects the lifelong continuum of care that women need, but also “reframes women’s health as a long-term market opportunity rather than a collection of one-off events,” the researchers said.
According to the report, nearly $60 billion was invested across women’s health from 2020 to 2025. Investments have initially focused on reproductive health, but researchers say women’s oncology and menopause are emerging as top areas of growth, areas that have traditionally been overlooked for funding.
The researchers estimate that as spending increases, each industry’s year-over-year growth rate through 2030 will be:
- Consumer technology: 14% to 17% annually
- Pharmaceuticals: 8% to 10% annually
- Payers and employers: 8% to 10% annually
- Providers and care delivery: 5% to 7% annually
- Devices and diagnostics: 4% to 6% annually
Researchers note that better identification of underdiagnosed conditions, scale of digital and artificial intelligence-enabled models, and expanded gender-specific research and development could also create new revenue streams.
“Health care leaders who act early can help determine the future of women’s health,” the report says. “Doing so could open up one of the more important value creation opportunities in modern healthcare.”
